Skip to main content
. 2024 Apr 29;9(2):e23.00133. doi: 10.2106/JBJS.OA.23.00133

TABLE I.

Demographic and Comorbidity Profile of the Shoulder Arthroplasty Cohort*

Variable All TSAs Nonfracture Fracture P Value
Case-level demographics
 Volume (no. [%]) 108,667 (100) 96,104 (88) 12,563 (12) NA
 5-year mortality (%) 16.6 14.9 29.9 <0.001
 Age at surgery, all (yr) 74.3 74.0 76.6 <0.001
 Age at death, if deceased (yr) 81.0 80.5 82.7 <0.001
 Female (%) 62.7 59.8 84.9 <0.001
 Non-White (%) 5.8 5.9 4.5 <0.001
Case-level comorbidities (%)
 BMI > 40 kg/m2 4.3 4.3 4.6 0.07
 CHF 6.0 5.6 8.7 <0.001
 COPD 10.8 10.6 12.4 <0.001
 Cancer 1.4 1.2 2.3 <0.001
 Diabetes 21.7 21.1 26.6 <0.001
 Kidney disease 1.4 1.0 3.8 <0.001
 Liver disease 0.4 0.4 0.7 <0.001
Hospital-level characteristics
 Annual surgical volume (no.) 2,622 2,506 2,167 NA
 Urban (%) 79.9 80.4 82.9 0.03
 Bed size (no.) 215.4 218.1 237.2 0.002
 Teaching (%) 37.4 37.5 40.9 0.01
*

NA = not applicable, BMI = body mass index, CHF = congestive heart failure, COPD = chronic obstructive pulmonary disease.

Values are given as the mean.